MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits
Clinical Review

New Drug Review from MPR (October 2013)

1.00 Credits

Archived CME/CE Courses


MPR Drug News

High Blood Sugar in Children May Slow Brain Growth

Chronic high blood sugar in young children may lead to slower brain development, new research by the National Institutes of Health (NIH) has shown.

"Keepsake" Fetal Imaging May Do More Harm Than Good, FDA Warns

The Food and Drug Administration (FDA) is warning consumers that fetal ultrasound imaging and Doppler fetal ultrasound heartbeat monitors are prescription devices designed to be used by trained healthcare professionals and are not intended for over-the-counter (OTC) sale or use for creating fetal keepsake images and videos.

First Pathogen Reduction System to Prep Plasma for Transfusion Approved

The Food and Drug Administration (FDA) has approved Cerus' Intercept Blood System for plasma, the first pathogen reduction system to use in preparation of plasma in order to reduce the risk of transfusion-transmitted infections (TTI).

No CVD, Insulin Improvements Seen with Low Glycemic Index Diet

In a new study published in the Journal of the American Medical Association, diets with low glycemic index of dietary carbohydrate do not appear to lead to a reduction in cardiovascular disease risk or improvement in insulin sensitivity.

Chlamydia, Gonorrhea Cases Down But Syphilis Rates Up

The Centers for Disease Control and Prevention (CDC) has released its annual fact sheet of the three reported sexually transmitted diseases (STDs): chlamydia, gonorrhea, and syphilis.